IDH1 and glioblastoma: GBM, also known as glioblastoma multiforme, was classified by the World Health Organization (WHO) in 2016 into IDH-wildtype and IDH-mutant subtypes based on the mutation status of isocitrate dehydrogenase (IDH) (Louis et al., 2016).